GroupAccess > Drug Coverage Guidelines

You are not signed in.

myBlueCross for Members
Forgot Username?
Forgot Password?

New to GroupAccess?

 

Search by Drug Name

  

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Product Name Implementation Date Guideline
NASACORT AQ® 04/01/04 The limits are 1 box per 30 days.
NASAREL® 08/06/08 The limits are 3 boxes per 30 days.
NASONEX® 02/22/05 The limits are 1 box – 17 g per 30 days.
NESINA 04/01/13 The limits are 1 tablet per day.
NEVIRAPINE 07/01/12 The limits are 40 mL per day.
NEXAVAR® 01/01/06 Prior authorization for medical necessity is required. The limits are 4 tablets per day.
NEXIUM® 01/01/00 Nexium may be subject to step therapy requirements. Patients must have trial and failure of generic lansoprazole, omeprazole, pantoprazole, or rabeprazole. The limits are 1 capsule or packet for oral suspension per day.
NICAZELDOXY® KIT 01/01/14 Nicazeldoxy may be subject to step therapy requirements. Patients must have trial and failure of generic immediate release doxycycline.
NORCO® 09/01/03 The limits are 12 for the 5 mg tablets and 6 for the 7.5 and 10 mg tablets per day. Patients should not take more than a total of 4 grams of acetaminophen per day (3 grams per day if you have liver disease).
NORDITROPIN® 10/01/11 Prior authorization for medical necessity is required. Use of the preferred growth hormone, Omnitrope, may be required.
NORVIR 07/01/12 The limits are 12 tablets or capsules or 16 mL per day.
NUCYNTA™ 07/06/09 The limits are 12 tablets per day.
NUCYNTA™ ER 01/01/12 The limits are 60 tablets per 30 days.
NUTRIDOX™ KIT 04/01/13 Nutridox may be subject to step therapy requirements. Patients must have trial and failure of generic immediate release doxycycline.
NUTROPIN AQ NUSPIN® 01/01/13 Prior authorization for medical necessity is required. Use of the preferred growth hormone, Omnitrope, may be required.

1 2